Optimal Volume of Bupivacaine in Adductor Canal Nerve Block

• Status: Unknown status
• Trial end date: 2017-03-01
• Target enrollment: 0
• Participant gender: Male

Summary

To establish adequate volume of levobupivacaine 0.25% in adductor canal nerve block in unilateral cruciate ligament of the knee reconstruction surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Pontificia Universidad Catolica de Chile
• Treatments: Bupivacaine; Levobupivacaine

Criteria

Inclusion Criteria:

• Male sex

• ASA status I or II

• BMI between 20 and 34 kg/m2

• Cruciate ligament of the knee reconstructive surgery

• No contraindications to general and regional anesthesia

Exclusion Criteria:

• Chronic pain more than 3 months

• Drug abuse

• Chronic use of analgesic drugs (more than 3 months)

• Psychiatric illness

• Peripheral neuropathy

• Drug allergy

• Severe gastroesophageal reflux disease